GeneReach Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	155.07	110.27	216.77	748.61	663.43
Short-Term Investments	114	181.01	285.95	-	-
Trading Asset Securities	20.69	122.7	-	-	-
Cash & Short-Term Investments	289.76	413.98	502.72	748.61	663.43
Cash Growth	-30.01%	-17.65%	-32.85%	12.84%	111.50%
Accounts Receivable	39.37	43.05	21.47	55.86	195.75
Other Receivables	2.16	3.37	1.68	0.4	0.72
Receivables	41.53	46.42	23.14	56.26	196.47
Inventory	32.56	37.52	67.37	235.81	268.3
Prepaid Expenses	1.88	3.24	5.88	8.36	34.68
Other Current Assets	118.43	93.51	33.01	21.03	17.66
Total Current Assets	484.16	594.67	632.14	1,070	1,181
Property, Plant & Equipment	284.73	359.65	433.83	436.93	397.11
Long-Term Investments	-	-	-	-	3.24
Other Intangible Assets	15.43	12.4	12.35	9.49	10.03
Long-Term Deferred Tax Assets	81.78	83.21	77.65	35.26	24
Other Long-Term Assets	14.95	16.56	20.18	70.15	69.51
Total Assets	881.05	1,066	1,176	1,622	1,684
Accounts Payable	7.19	7.74	8.86	13.35	31.68
Short-Term Debt	136	171	104	49	49
Current Portion of Long-Term Debt	-	-	35.62	204.42	7.5
Current Portion of Leases	11.4	11.64	11.38	12.64	8.54
Current Income Taxes Payable	-	7	3.59	23.08	74.45
Current Unearned Revenue	3.34	2.93	4.96	7.8	19.43
Other Current Liabilities	43.2	39.21	37.5	74.8	87.62
Total Current Liabilities	201.13	239.53	205.9	385.09	278.21
Long-Term Debt	-	-	-	15	217.39
Long-Term Leases	71.7	84.59	97.74	108.89	87.35
Long-Term Unearned Revenue	9.53	10.57	8.78	8.95	8.82
Pension & Post-Retirement Benefits	-	-	-	-	1.73
Long-Term Deferred Tax Liabilities	1.99	6.29	1.26	1.28	1.2
Other Long-Term Liabilities	-	0.02	0.02	0.02	1.64
Total Liabilities	284.34	341	313.71	519.23	596.35
Common Stock	580.58	574.58	574.58	459.66	417.87
Additional Paid-In Capital	150.54	144.9	144.9	144.9	144.9
Retained Earnings	-117.32	-3.29	114.74	464.44	491.74
Treasury Stock	-17.31	-	-	-	-
Comprehensive Income & Other	-9.76	0.79	-2.15	-1.33	-4.7
Total Common Equity	586.73	716.98	832.06	1,068	1,050
Minority Interest	9.99	8.51	30.37	35.01	38.26
Shareholders' Equity	596.72	725.49	862.44	1,103	1,088
Total Liabilities & Equity	881.05	1,066	1,176	1,622	1,684
Total Debt	219.1	267.23	248.74	389.95	369.78
Net Cash (Debt)	70.67	146.75	253.98	358.66	293.65
Net Cash Growth	-51.84%	-42.22%	-29.19%	22.14%	133.48%
Net Cash Per Share	1.24	2.55	4.42	6.05	5.01
Filing Date Shares Outstanding	57.3	57.46	57.46	57.46	57.46
Total Common Shares Outstanding	57.3	57.46	57.46	57.46	57.46
Working Capital	283.03	355.14	426.24	684.99	902.32
Book Value Per Share	10.24	12.48	14.48	18.58	18.27
Tangible Book Value	571.29	704.59	819.72	1,058	1,040
Tangible Book Value Per Share	9.97	12.26	14.27	18.42	18.10
Buildings	296.08	293.85	292.04	267.33	266.03
Machinery	306.55	332.71	309.58	273.19	231.16
Construction In Progress	0.26	-	-	20.95	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.